Alternative splicing allows organisms to rapidly modulate protein functions to physiological changes and therefore represents a highly versatile adaptive process. We investigated the conservation of the evolutionary history of the ''Fox'' family of RNA-binding splicing factors (RBFOX) as well as the conservation of regulated alternative splicing of the genes they control. We found that the RBFOX proteins are conserved in all metazoans examined. In humans, Fox proteins control muscle-specific alternative splicing of many genes but despite the conservation of splicing factors, conservation of regulation of alternative splicing has never been demonstrated between man and nonvertebrate species. Therefore, we studied 40 known Fox-regulated human exons and found that 22 had a tissue-specific splicing pattern in muscle and heart. Of these, 11 were spliced in the same tissue-specific manner in mouse tissues and 4 were tissue-specifically spliced in muscle and heart of the frog Xenopus laevis. The inclusion of two of these alternative exons was also downregulated during tadpole development. Of the 40 in the starting set, the most conserved alternative splicing event was in the transforming growth factor (TGF) beta-activated kinase Tak1 (MAP3K7) as this was also muscle specific in urochordates and in Ambulacraria, the most ancient deuterostome clade. We found exclusion of the muscle-specific exon of Tak1 was itself under control of TGF beta in cell culture and consistently that TGF beta caused an upregulation of Fox2 (RBFOX2) expression. The alternative exon, which codes for an in-frame 27 amino acids between the kinase and known regulatory domain of TAK1, contains conserved features in all organisms including potential phosphorylation sites and likely has an important conserved function in TGF beta signaling and development. This study establishes that deuterostomes share a remarkable conserved physiological process that involves a splicing factor and expression of tissue-specific isoforms of a target gene that expedites a highly conserved signaling pathway.
Introduction
Alternative splicing enables a limited number of genes to encode a far greater number of proteins in all multicellular organisms (Black 2003; Elliott and Ladomery 2011) . Alternative isoforms can be expressed in a tissue-specific and temporally regulated manner under the control of pre-mRNA-binding proteins. For example, the neural-specific splicing factor Nova has been shown to control neural-specific splicing of five (aplp2, brd9, kcnma1, neo1, and ptprf) conserved target exons in mammals and fish (Jelen et al. 2007) . A homolog of the Nova protein (pasilla) has been found in flies, and genome-wide studies have identified common target genes in flies and mammals, although these were not found to be in orthologous exons (Brooks et al. 2011) . Indeed, regulated alternative exons that are conserved between deuterostome and protostome species are likely to be extremely rare, as the two lineages have undergone extreme adaptations in their splicing programs. Consistent with this expectation, Nova is expressed in neurons in vertebrates but predominantly in the salivary gland of protostomes (Irimia et al. 2011) .
The original Fox (feminizing on the X) protein was discovered in Caenorhabditis. elegans, and there are three homologs in mammals, RBFOX1, RBFOX2, and RBFOX3 (Kuroyanagi 2009 ). The proteins are known to function as controllers of alternative splicing by binding to UG-CAUG sequences in RNA. Furthermore, they have an exquisite mode of action whereby binding downstream of exons enhances their recognition and binding upstream within the extended 3# splices site, branch point, and polypyrimdine tract inhibits exon inclusion. Fox proteins control alternate splicing of many different genes in heart and muscle in mammals (Das et al. 2007; Kalsotra et al. 2008; Bland et al. 2010; Han et al. 2011 ) among which are several involved in cytoskeletal remodeling and invasion (Das et al. 2007; Zhang et al. 2008; Venables et al. 2009; Yeo et al. 2009 ). Fox proteins also likely control inclusion of alternative exons in their own genes, allowing them to autoregulate their own activity (Damianov and Black 2010) .
Despite the conservation of splicing factors between C. elegans and man, conservation of tissue-specific alternative splicing between vertebrates and other taxa had not been described. To address this issue, we looked in diverse organisms for the presence of Fox genes and found them to be conserved in all metazoans. We also looked at the alternative splicing pattern of 40 established targets of the human splicing factor Fox2, including the transforming growth factor (TGF) beta-activated kinase TAK1/MAP3K7 (Venables et al. 2009 ). TAK1 is the major intracellular mediator of the highly conserved TGF beta/BMP signaling pathway (Shibuya et al. 1998; Yamaguchi et al. 1999; Massague 2008) and it is implicated in many other different signaling pathways including TNF and interleukin as well as affecting JNK and p38 activities (Li et al. 2003) . TAK1 was also recently shown to be essential for muscle development and the differentiation-associated activation of p38 and Akt kinases (Bhatnagar et al. 2010) . Tak1 is expressed as four tissue-specific isoforms (Kondo et al. 1998; Dempsey et al. 2000) . The two major isoforms differ by a 27 amino acid stretch encoded by the short exon that we previously identified as a putative Fox2 target but no difference in function has been demonstrated between the two isoforms, and the longer isoform has scarcely been considered before.
Here, we show that muscle-specific exclusion of an alternative exon of Tak1 is conserved in all deuterostomes examined. Gene comparison in organisms from mammals to sea urchin and acorn worm reveals an exquisite use of alternative splicing strategies during evolution. Although little attention has been hitherto given to TAK1 isoforms, our study shows that the Tak1 gene has the most conserved regulated alternative splicing pattern so far reported, which supports basic and distinct functional roles for TAK1 isoforms in TGF beta signaling.
Materials and Methods
Reverse Transcriptase-Polymerase Chain Reaction Cells were harvested in Tri reagent (Sigma) and, reverse transcriptase-polymerase chain reaction (RT-PCR) was performed with first strand cDNA synthesis kit from GE HealthCare. RT-PCR reactions from 60-ng RNA were used as template for a 50-ll PCR reaction with 50 pmol of each primer (listed in supplementary table S1, Supplementary Material online) using platinum Taq (Invitrogen) at 94°C for 2 min then 35 cycles of 94°C, 55°C and 72°C for 30 s each then 2 min at 72°C. PCR products were run on a 1.5% agarose TBE gel and stained with ethidium bromide for imaging. For sea urchin whose Tak1 gene shows high G þ C content, reverse transcription was performed with the maxima first strand cDNA synthesis kit (Fermentas) and included a 0.5 lM specific primer GAGCCATCCTC ATGTGTTCA. Ten rounds of nested PCR were then performed with forward and reverse primers TTCAGTGATCT TCCCCCTGT and TGGAATTAGGATTGGGTGGA, and 0.5 ll was used in a hot start for 35 rounds with forward and reverse primers CCGACCTCAAAGGAACAGAA and ACCACCTCTGCTCCAGTGAC.
Quantification of PCR ratios was performed with Genetools software (Syngene) using automatic band assignment and background correction. Raw band volumes were converted to concentrations in arbitrary units by dividing by the PCR product size, and percent spliced in values were calculated by dividing the long band concentration by the sum of the long and short (see supplementary table S1, Supplementary Material online).
Database Searches
Blastp and tblastn searches for RBFox, Tak1/MAP3K7, Sec3/ ExoC1, MYO18A, and SYNE2 orthologous sequences in nr, reference genomic sequences, reference mRNA, and EST databases were performed using the NCBI Blast suite http://blast.ncbi.nlm.nih.gov/. Short alternative exons were identified by Staden diagon analysis of introns translated into three reading frames.
Phylogenetic Inference
Trees were inferred by using MrBayes (Huelsenbeck and Ronquist 2001) and PhyML (Guindon et al. 2010) . Kinase (Tak1 kinase) or RRM (Fox splicing factors) sequences (supplementary tables S2 and S3, Supplementary Material online) were aligned with MAFFT (Katoh et al. 2002) . Alignments were analyzed with ProtTest (v. 10.2) to identify the best substitution models (Abascal et al. 2005) . We used MrBayes 3.1.2 with the wag matrix rate and a gamma distribution describing among-site rate variation with eight categories (þG8). MCMCMC chains were run for 1 million generations with a sample frequency of 1,000 and a 10% burn in value. For maximum likelihood (ML) analyses, we also used the wag þ G8 in PhyMLM while searching for the ML tree by performing both nearest neighbor interchange and subtree pruning and regrafting topological moves on a bioNJ starting tree. The statistical robustness of inferred nodes was assessed by 100 bootstrap pseudoreplicates of the same ML search. Whatever the method and the data set (amino acids or codons) trees inferred showed the same topologies. Silent versus nonsilent K s /K a ratios of substitutions between Ciona intestinalis and Ciona savignyi Fox and Tak1 open reading frames (supplementary table S4, Supplementary Material online) were calculated using the KaKs calculator program (Zhang et al. 2006 ).
Cell Culture
Normal murine mammary gland (NMuMG) cells were cultivated at 37°C in the presence of 5% CO 2 in Dulbecco's modified Eagle medium supplemented with 10% (v/v) fetal calf serum. Cells were plated in 12-mm glass cover slips 16-24 h before TGF beta stimulation. After TGF beta stimulation (5 ng.ml À1 ), cells were fixed for 10 min in 3.7% (v/v) formalin-phosphate-buffered saline (PBS). After 10 min permeabilization in 0.1% Triton X-100 in PBS and a 30 min incubation at room temperature in 0.1% bovine serum albumin (BSA)-PBS, cells were processed for immunohistochemistry. Cover slips were incubated for 1 h at 37°C with the anti-E-cadherin antibody (0.25 lg.ml À1 in PBS 0.1% BSA, BD Transduction Laboratories), washed twice with PBS, then stained for F-actin using rhodamine-conjugated phalloidin. Cells were washed with PBS, mounted in Mowiol (Aldrich) and visualized by fluorescence microscopy (AX10 Imager.M1, Zeiss). Images were captured with an AxioCam MRm camera (Zeiss). Western blotting was performed with Venables et al. · doi:10.1093/molbev/msr193 MBE Fox 1, 2, and 3 serum as described in Han et al. (2011) and purified with the gel Melon IgG purification kit (Thermo).
Animal Husbandry
Xenopus laevis embryos were obtained by in vitro fertilization, grown as previously described (Vignal et al. 2007 ) and conventionally staged (Nieuwkoop and Faber 1967) . Adults of C. intestinalis and Paracentrotus lividus were collected in the bay of Roscoff (Finistère) France.
Results
Splicing factors of the Fox family are highly conserved in vertebrates and ecdysozoans (Kuroyanagi 2009; Damianov and Black 2010) . To complete the evolutionary picture, we searched for Fox orthologs in genomic and mRNA databases. We found Fox-like proteins in all metazoans, from Placozoans (Trichoplax adhaerens), but not in the unicellular choanoflagellate Monosiga brevicollis ( fig. 1 ). This strong evolutionary conservation in multicellular animals suggests that Fox proteins control basic physiological functions associated with cell differentiation. Interestingly, phylogenetic analysis also revealed a discrepant branching of urochordates, suggestive of a regressive evolution of Fox proteins in this clade.
Fox proteins have the highest binding specificity of known RNA-binding protein splicing factors with a defined binding site UGCAUG. This sequence was found in a genome-wide screen of alternative splicing events to be highly over represented near predicted muscle and heart-specific exons A Conserved Tissue-Specific Splicing Event · doi:10.1093/molbev/msr193 MBE correlating with the highest expression of Fox proteins in these tissues (Das et al. 2007; Castle et al. 2008 ). Many Fox target exons are also highly conserved and the Fox-binding sites near the exons are too (supplementary fig. S1 , Supplementary Material online). However, the conservation of tissue specificity of their splicing patterns has not been investigated. First, we sought to confirm muscle-and heart-specific splicing of Fox substrates; we performed an RT-PCR analysis of the 40 strongest experimentally confirmed Fox targets from a recent study (Venables et al. 2009 ) (supplementary figs. S1 and S2, Supplementary Material online). By analyzing six different human tissues, we observed 22 targets showing clear differences (.20% on average) in alternative exon inclusion between kidney and liver on the one hand and heart and muscle on the other ( fig. 2a and supplementary table S1 , Supplementary Material online).
We next examined which targets display alternative splicing events conserved across evolution. We analyzed four mouse tissues (kidney, liver, heart, and muscle) and found that 11 of the 22 conserved alternative splicing events showed the same direction of shifts in splicing as had been seen in human ( fig. 2b) . We further probed the conservation in frogs. Six target exons were conserved in the frog genome and four displayed tissue-specific alternative splicing in X. laevis liver versus heart and muscle: TGF beta associated kinase Tak1 (MAP3K7), Exocyst component Sec3 (ExoC1), Myosin (MYO18A), and SYNE2 ( fig. 2c) .
To further probe alternate splicing conservation, we searched available metazoan genomes for potential alternative exons in the four genes. Only the TAK1 gene was identified in all metazoan genomes analyzed (supplementary table S2, Supplementary Material online); we found exons potentially encoding the Tak1 alternative peptide MBE at the expected position in all deuterostome species examined but not for the other three vertebrate-conserved splicing events and no conservation of the alternative peptides could be identified in protostomes (table 1). We then confirmed in the intestine and muscle of the prochordate sea squirt (C. intestinalis) that the Tak1 exon identified in silico indeed showed muscle-specific exclusion as had been found in mammals ( fig. 3a) . Finally, we examined Tak1 expression in sea urchin, where the potential alternatively spliced peptide is included in a 624 nucleotide exon. Like in other deuterostomes, we found the exon was strictly removed in muscle but remained included in intestine ( fig. 3b  and c) . Inhibition of the exon also resulted in some use of a cryptic splice in the exon (supplementaryfig. S3, Supplementary Material online).
TAK1 is a crucial effector of the TGF beta-mediated mesoderm induction in Xenopus (Ohkawara et al. 2004 ). Therefore, we looked to see if the Fox-regulated splicing events were altered during X. laevis embryonic development. We observed striking temporally regulated exclusion of the alternative exons of Tak1 and Sec3 between the neurula and tadpole stages, concomitant with muscle development ( fig. 4a) .
In vitro, TGF beta is the classic cytokine for induction of epithelial to mesenchymal transition (EMT). We therefore used a well-established in vitro model of TGF betamediated EMT in mouse NMuMG cells (Bhowmick et al. 2001 ) to investigate conserved Fox-mediated regulation of alternative splicing. As expected, treatment with 5 ng.ml À1 TGF beta caused changes indicative of EMT over 24 h (supplementary fig. S4 , Supplementary Material online). Western blotting also showed TGF beta caused a strong induction of Fox2 expression ( fig. 4b) . Consistently, Tak1 splicing was altered after 24-h treatment with TGF beta, with a shift from the long isoform to the short one. This is also in complete agreement with the action of Fox2 as repressor of the inclusion of the Tak1 exon. Consistent with Fox2 upregulation during EMT in NMuMG cells, the four most conserved splicing events (from fig. 2c ) were significantly shifted by TGF beta treatment ( fig. 4c ).
Discussion
In this study, we demonstrate that a conserved 27 amino acid peptide of TAK1 is excluded through alternative splicing in the muscles of mammals, frog, sea squirt, and sea urchin. Although conservation of alternatively spliced exons has been documented in vertebrates (Jelen et al. 2007 ), Tak1 represents the first example of conserved tissue-regulated alternative splicing in deuterostomes. Other candidate genes were the fibroblast growth factor FGFR2, shown to use two 
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a Amino acids conserved across species are in italics. Proline residues are underlined. A Conserved Tissue-Specific Splicing Event · doi:10.1093/molbev/msr193 MBE mutually exclusive exons in C. elegans and mammals depending on cellular states and Tra2, whose alternative splicing was reported in Drosophila and man (McGuffin et al. 1998; Kuroyanagi 2009 ). In Tra2, an intron is regulated in flies, whereas an exon is regulated in mammals. In FGFR2, the mutually exclusive exons are in different parts of the protein in deuterostomes and protostomes, so these are likely examples of alternative splicing evolution converging on common genes and do not represent orthologous splicing events. However, the alternative splicing of exons IIIb and IIIc of FGFR2 occurred relatively early on in deuterostome evolution (Bhatnagar et al. 2010) , although the sea urchin has only one exon in this region and we found no evidence of alternative splicing of this exon in four sea urchin tissues (data not shown). In chordates, the regulated exon in Tak1 is of a fixed size of 81 nucleotides (except the horse exon, which codes an extra four amino acids, see table 1 and supplementary fig.  S1 , Supplementary Material online), whereas in the Ambulacraria clade, which includes hemichordates and echinoderms (Turbeville et al. 1994 ), the peptide is encoded by the 5# end of a much larger exon (fig. 5) . In hemichordates (acorn worm), two Tak1 isoforms might be generated from a tandem-repeated cassette containing the alternative 27 amino acids, which supports a scenario in which the Tak1 gene ancestor in deuterostomes already contained the alternatively spliced exon. Furthermore, we observed a preponderance of Fox-binding sites in the intron upstream of the alternative exon in all species except Ciona suggesting that Fox proteins already controlled Tak1 gene alternative splicing in early deuterostome evolution (fig. 5) . The absence of the hexameric Fox-binding sites upstream of the alternatively spliced Tak1 exon and the divergence of the RRM domain of Fox ( fig. 1) are features shared by both C. intestinalis and C. savignyi species (Data not shown), which suggests a relaxation of the constraints exerted on the two genes. However, we found low K a /K s ratios between Fox and Tak1 coding sequences of C. intestinalis and C. savignyi (below 0.07 whatever the substitution model, P value , 5.4 Â 10
À57
, supplementarytable S4, Supplementary Material online). This indicates that the two genes are still under strong purifying selection in Cionidae and suggests that the observed relaxation likely affects the functional link between the Fox and Tak1 genes. In this respect, Cionidae, thus appear more similar to insects and nematodes ( fig. 1b) , in which there is no Tak1 alternative exon that could be controlled by Fox proteins (fig. 5) .
Previous studies have suggested, that for the most part, alternative splicing regulators are highly conserved in evolution, but that these conserved regulators acquire new target exons in a species-specific manner (Jelen et al. 2007; Brooks et al. 2011; Irimia et al. 2011) . Indeed, only one-third of human alternative splicing events can be found in mouse (Mudge et al. 2011) . Our finding of conserved regulation of only half of the 22 Fox target exons between human and mouse is consistent with this modest conservation (fig. 2b) ; however, the extreme conservation of Tak1 alternative splicing in sea squirt ( fig. 2a ) and the disappearance of the Fox elements in this species ( fig. 5 ) imply that some key alternative splicing events have essential developmental functions, whereas the upstream genes controlling them may vary, as has been observed for the alternative splicing cascade controlling sex determination in flies (Shukla and Nagaraju 2010) . An alternative possibility is that the urochordate Fox proteins have acquired an altered RNA-binding specificity that is mirrored in their Tak1 transcript.
Core components of the TGF beta pathway were shown recently to have emerged in early metazoans (Huminiecki et al. 2009 ). Our study extends this early emergence to Tak1 and to RNA-binding proteins of the RBFOX family. Furthermore, the fact that Fox2 is induced upon TGF beta treatment together with the timing of occurrence of the Tak1 alternative exon strongly suggests that deuterostomes have selected Fox2-dependent alternative splicing as an integral part of TGF beta signaling. This may also be the case for other physiological functions of TGF beta, such as chondrogenic differentiation in which the SRp40 splicing factor is induced (Han et al. 2007) or angiogenesis, in which TGF beta induces a switch in VEGF isoforms that depends on the splicing factor SRp55 (Nowak et al. 2008) . 
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Sequence analysis of TAK1 alternative peptides showed highly conserved features from acorn worm to man; peptides are flanked by prolines and contain basic residues, potential sites for PKA-or CK1-dependent phosphorylation, as well as putative binding sites, and PDZ, SH2, and PP2B domains (http://elm.eu.org/, data not shown). Several TAK1-binding proteins (TABs) have already been reported, whose implication in TAK1 signaling have been largely documented: TAB1, interacting with the kinase domain at the N-terminus (Yamaguchi et al. 1999 ), TAB2 and TAB3 that interact with the C-terminal coiled-coil domain (Takaesu et al. 2000) and TAB4/TIP41, a negative regulator of the TOR pathway (Jacinto et al. 2001) , which also binds to the central region of TAK1 (Prickett et al. 2008) . TAB proteins are highly conserved across evolution, especially TAB4 which is found in all eukaryotes (supplementary table S5, Supplementary Material online). Interestingly, the TAK1 alternative peptide is located near the TAB4-binding region directly adjacent to a residue that is phosphorylated upon TAB4 binding. Loss of the alternative peptide in TGF betatreated cells might thus modify the distribution of TAK1 complexes and induce different cellular outcomes.
In conclusion, this study emphasizes the use of evolutionary studies to identify conserved regulatory features. The conservation of the Tak1 alternative splicing pattern in deuterostomes therefore suggests that this feature adapts tissue-specific cell physiology to external signaling and implies a major functional difference between the TAK1 isoforms which calls for further investigation.
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